lastID = -291537
Skip to main content Skip to top navigation Skip to site search
Top of page
  • My citations options
    Web Back (from Web)
    Chicago Back (from Chicago)
    MLA Back (from MLA)
Close action menu

You need to login to use this feature.

Please wait a moment…
Please wait while we update your results...
Please wait a moment...
Description: Access Water
Context Menu
Description: Book cover
FORMULATION AND ISSUES IN THE IMPLEMENTATION OF DISPOSABLE STANDARDS FOR ANAEROBICALLY TRANSFORMED INTERMEDIATES OF ANTIBIOTIC PHARMACEUTICAL INDUSTRY – A CASE STUDY
  • Browse
  • Compilations
    • Compilations list
  • Subscriptions
Tools

Related contents

Loading related content

Workflow

No linked records yet

X
  • Current: 2022-05-06 14:58:32 Adam Phillips
  • 2022-05-06 14:58:31 Adam Phillips
  • 2020-03-26 23:21:45 Adam Phillips
  • 2020-01-31 23:17:36 Administrator
  • 2020-01-31 23:17:35 Administrator
  • 2020-01-31 23:17:34 Administrator
Description: Access Water
  • Browse
  • Compilations
  • Subscriptions
Log in
0
Accessibility Options

Base text size -

This is a sample piece of body text
Larger
Smaller
  • Shopping basket (0)
  • Accessibility options
  • Return to previous
Description: Book cover
FORMULATION AND ISSUES IN THE IMPLEMENTATION OF DISPOSABLE STANDARDS FOR ANAEROBICALLY TRANSFORMED INTERMEDIATES OF ANTIBIOTIC PHARMACEUTICAL INDUSTRY – A CASE STUDY

FORMULATION AND ISSUES IN THE IMPLEMENTATION OF DISPOSABLE STANDARDS FOR ANAEROBICALLY TRANSFORMED INTERMEDIATES OF ANTIBIOTIC PHARMACEUTICAL INDUSTRY – A CASE STUDY

FORMULATION AND ISSUES IN THE IMPLEMENTATION OF DISPOSABLE STANDARDS FOR ANAEROBICALLY TRANSFORMED INTERMEDIATES OF ANTIBIOTIC PHARMACEUTICAL INDUSTRY – A CASE STUDY

  • New
  • View
  • Details
  • Reader
  • Default
  • Share
  • Email
  • Facebook
  • Twitter
  • LinkedIn
  • New
  • View
  • Default view
  • Reader view
  • Data view
  • Details

This page cannot be printed from here

Please use the dedicated print option from the 'view' drop down menu located in the blue ribbon in the top, right section of the publication.

screenshot of print menu option

Description: Book cover
FORMULATION AND ISSUES IN THE IMPLEMENTATION OF DISPOSABLE STANDARDS FOR ANAEROBICALLY TRANSFORMED INTERMEDIATES OF ANTIBIOTIC PHARMACEUTICAL INDUSTRY – A CASE STUDY
Abstract
The formulation and implementation of regulatory standards for the ultimate disposal and reuse of transformed products of antibiotic drugs and solvents have been a pending issue in the waste management of pharmaceutical industries especially in the developing countries like India. A case study has been identified and the current issues in one of the major pharmaceutical industry (manufacturing cephalosporin drugs) located in Chennai, India, has been discussed for the possible implementation of transformed intermediate products. The objective of the study were to discuss the issues in the implementation of the disposal standards for effective waste management in pharmaceutical industries. Cephalosporins are widely manufactured and used for the therapy of acute pneumonia and infections of respiratory tract, skin and soft tissues, bones and joints, urinary tract and blood stream (Goodman, 1980). Cephalosporin is a common name refers to cephradine (C16H19N3O4S) and cephalexin (C16H17N3O4S.H2O) (British Pharmacopoeia, 1980). Based on the critical examination of results the industry is looking for the alternatives of either direct disposal of 7-amino-3-deacetoxycephalosporanic acid (7-ADCA) and Phenyl acetic acid or for further degradation and disposal, which will essentially require additional cost and maintenance. The present regulatory standard implemented in India does not envisage such disposal alternatives and hence this would invite suggestions and recommendations of the expertise for the possible implementation on the pending issue in the antibiotic based pharmaceutical industries. The presence of cephalosporin increases total strength (Chemical Oxygen Demand) of the effluent and indirectly increases the cost of the treatment. Hence the biotransformation of cephalosporin either alone or in combination with other energetic compounds, offers the potential for an economical and environmentally friendly disposal alternative.
The formulation and implementation of regulatory standards for the ultimate disposal and reuse of transformed products of antibiotic drugs and solvents have been a pending issue in the waste management of pharmaceutical industries especially in the developing countries like India. A case study has been identified and the current issues in one of the major pharmaceutical industry (manufacturing...
Author(s)
R. SaravananeM. A. SivasankaranV. Murugaiyan
SourceProceedings of the Water Environment Federation
SubjectSession 11: Pharmaceutical Industry Wastewater Treatment
Document typeConference Paper
PublisherWater Environment Federation
Print publication date Jan, 2004
ISSN1938-6478
SICI1938-6478(20040101)2004:6L.574;1-
DOI10.2175/193864704784106165
Volume / Issue2004 / 6
Content sourceIndustrial Wastes (IW) Conference
First / last page(s)574 - 581
Copyright2004
Word count289

Purchase price $11.50

Get access
Log in Purchase content Purchase subscription
You may already have access to this content if you have previously purchased this content or have a subscription.
Need to create an account?

You can purchase access to this content but you might want to consider a subscription for a wide variety of items at a substantial discount!

Purchase access to 'FORMULATION AND ISSUES IN THE IMPLEMENTATION OF DISPOSABLE STANDARDS FOR ANAEROBICALLY TRANSFORMED INTERMEDIATES OF ANTIBIOTIC PHARMACEUTICAL INDUSTRY – A CASE STUDY'

Add to cart
Purchase a subscription to gain access to 18,000+ Proceeding Papers, 25+ Fact Sheets, 20+ Technical Reports, 50+ magazine articles and select Technical Publications' chapters.
Loading items
There are no items to display at the moment.
Something went wrong trying to load these items.
Description: Book cover
FORMULATION AND ISSUES IN THE IMPLEMENTATION OF DISPOSABLE STANDARDS FOR ANAEROBICALLY TRANSFORMED INTERMEDIATES OF ANTIBIOTIC PHARMACEUTICAL INDUSTRY – A CASE STUDY
Pricing
Non-member price: $11.50
Member price:
-291537
Get access
-291537
Log in Purchase content Purchase subscription
You may already have access to this content if you have previously purchased this content or have a subscription.
Need to create an account?

You can purchase access to this content but you might want to consider a subscription for a wide variety of items at a substantial discount!

Purchase access to 'FORMULATION AND ISSUES IN THE IMPLEMENTATION OF DISPOSABLE STANDARDS FOR ANAEROBICALLY TRANSFORMED INTERMEDIATES OF ANTIBIOTIC PHARMACEUTICAL INDUSTRY – A CASE STUDY'

Add to cart
Purchase a subscription to gain access to 18,000+ Proceeding Papers, 25+ Fact Sheets, 20+ Technical Reports, 50+ magazine articles and select Technical Publications' chapters.

Details

Description: Book cover
FORMULATION AND ISSUES IN THE IMPLEMENTATION OF DISPOSABLE STANDARDS FOR ANAEROBICALLY TRANSFORMED INTERMEDIATES OF ANTIBIOTIC PHARMACEUTICAL INDUSTRY – A CASE STUDY
Abstract
The formulation and implementation of regulatory standards for the ultimate disposal and reuse of transformed products of antibiotic drugs and solvents have been a pending issue in the waste management of pharmaceutical industries especially in the developing countries like India. A case study has been identified and the current issues in one of the major pharmaceutical industry (manufacturing cephalosporin drugs) located in Chennai, India, has been discussed for the possible implementation of transformed intermediate products. The objective of the study were to discuss the issues in the implementation of the disposal standards for effective waste management in pharmaceutical industries. Cephalosporins are widely manufactured and used for the therapy of acute pneumonia and infections of respiratory tract, skin and soft tissues, bones and joints, urinary tract and blood stream (Goodman, 1980). Cephalosporin is a common name refers to cephradine (C16H19N3O4S) and cephalexin (C16H17N3O4S.H2O) (British Pharmacopoeia, 1980). Based on the critical examination of results the industry is looking for the alternatives of either direct disposal of 7-amino-3-deacetoxycephalosporanic acid (7-ADCA) and Phenyl acetic acid or for further degradation and disposal, which will essentially require additional cost and maintenance. The present regulatory standard implemented in India does not envisage such disposal alternatives and hence this would invite suggestions and recommendations of the expertise for the possible implementation on the pending issue in the antibiotic based pharmaceutical industries. The presence of cephalosporin increases total strength (Chemical Oxygen Demand) of the effluent and indirectly increases the cost of the treatment. Hence the biotransformation of cephalosporin either alone or in combination with other energetic compounds, offers the potential for an economical and environmentally friendly disposal alternative.
The formulation and implementation of regulatory standards for the ultimate disposal and reuse of transformed products of antibiotic drugs and solvents have been a pending issue in the waste management of pharmaceutical industries especially in the developing countries like India. A case study has been identified and the current issues in one of the major pharmaceutical industry (manufacturing...
Author(s)
R. SaravananeM. A. SivasankaranV. Murugaiyan
SourceProceedings of the Water Environment Federation
SubjectSession 11: Pharmaceutical Industry Wastewater Treatment
Document typeConference Paper
PublisherWater Environment Federation
Print publication date Jan, 2004
ISSN1938-6478
SICI1938-6478(20040101)2004:6L.574;1-
DOI10.2175/193864704784106165
Volume / Issue2004 / 6
Content sourceIndustrial Wastes (IW) Conference
First / last page(s)574 - 581
Copyright2004
Word count289

Actions, changes & tasks

Outstanding Actions

Add action for paragraph

Current Changes

Add signficant change

Current Tasks

Add risk task

Connect with us

Follow us on Facebook
Follow us on Twitter
Connect to us on LinkedIn
Subscribe on YouTube
Powered by Librios Ltd
Powered by Librios Ltd
Authors
Terms of Use
Policies
Help
Accessibility
Contact us
Copyright © 2024 by the Water Environment Federation
Loading items
There are no items to display at the moment.
Something went wrong trying to load these items.
Description: WWTF Digital Boot 180x150
WWTF Digital (180x150)
Created on Jul 02
Websitehttps:/­/­www.wef.org/­wwtf?utm_medium=WWTF&utm_source=AccessWater&utm_campaign=WWTF
180x150
R. Saravanane# M. A. Sivasankaran# V. Murugaiyan. FORMULATION AND ISSUES IN THE IMPLEMENTATION OF DISPOSABLE STANDARDS FOR ANAEROBICALLY TRANSFORMED INTERMEDIATES OF ANTIBIOTIC PHARMACEUTICAL INDUSTRY – A CASE STUDY. Alexandria, VA 22314-1994, USA: Water Environment Federation, 2018. Web. 26 Sep. 2025. <https://www.accesswater.org?id=-291537CITANCHOR>.
R. Saravanane# M. A. Sivasankaran# V. Murugaiyan. FORMULATION AND ISSUES IN THE IMPLEMENTATION OF DISPOSABLE STANDARDS FOR ANAEROBICALLY TRANSFORMED INTERMEDIATES OF ANTIBIOTIC PHARMACEUTICAL INDUSTRY – A CASE STUDY. Alexandria, VA 22314-1994, USA: Water Environment Federation, 2018. Accessed September 26, 2025. https://www.accesswater.org/?id=-291537CITANCHOR.
R. Saravanane# M. A. Sivasankaran# V. Murugaiyan
FORMULATION AND ISSUES IN THE IMPLEMENTATION OF DISPOSABLE STANDARDS FOR ANAEROBICALLY TRANSFORMED INTERMEDIATES OF ANTIBIOTIC PHARMACEUTICAL INDUSTRY – A CASE STUDY
Access Water
Water Environment Federation
December 22, 2018
September 26, 2025
https://www.accesswater.org/?id=-291537CITANCHOR